In line with the results from this study, the majority of reports on the prognostic impact of EGFR expression in gastric and esophageal adenocarcinoma have demonstrated correlations with shorter OS[20, 21, 29, 33], although one study found an independent correlation to a longer OS[63]. The gene discussed is EGFR; the disease is esophageal adenocarcinoma.